Meeting the Need: The ZEISS Myopia Collective

Myopia is no longer considered to be a simple refractive error that can be corrected by a pair of spectacles. It is well recognized that it is an escalating public health challenge, with consequences extending well beyond blurred distance vision.¹ It is within this context that the need for a myopia management ecosystem, involving practitioners, research community, industry and public health organizations, has never mattered more.

Practitioners are at the coal face of the myopia challenge, being the first point of contact for children, their families and the primary caregivers. For them to be able to provide the appropriate care, they require access to several interconnected resources.

These resources include:

1. Therapeutic interventions to slow the progression of myopia. This includes spectacle lenses with features that induce defocus, contact lenses with multifocality, or orthokeratology lenses.
2. Diagnostic and monitoring infrastructure: Effective myopia management is evidence-driven and longitudinal. This requires robust diagnostic capabilities, such as: Autorefractors and subjective refraction to quantify refractive error, biometers to measure axial length and monitor its progression, corneal topographers to assess corneal shape and suitability for contact lens and orthokeratology fittings and posterior segment imaging (fundus cameras, OCT) where indicated, to evaluate retinal and choroidal health in higher-risk eyes. Together, these tools support informed treatment decisions and ongoing risk assessment.
3. Clinical support, data and community: Beyond products and instrumentation, practitioners benefit from: Educational resources that synthesize emerging evidence and evolving guidelines; software platforms that track refractive error, axial length and treatment outcomes over time; and peer networks and professional communities that enable sharing of clinical experience, protocols and practical insights. These supports help clinicians refine their approach and maintain confidence in a rapidly evolving field.
4. Practice and Business Systems: To integrate myopia management sustainably into daily practice, clinicians also require: Digital platforms that streamline patient flow, recall systems, ordering and inventory; clear communication tools and patient education materials; and workflow frameworks that make it simple for the entire practice team to deliver consistent, high-quality myopia care. In this context, industry’s role is not merely to supply products, but to understand the realities of clinical practice and help create conditions where myopia management can thrive.

Within the myopia management ecosystem, industry is an active partner with defined responsibilities. Companies operating in this space are expected to understand and respond to stakeholder needs rigorously, transparently, ethically and in a timely manner.

This begins with listening. Industry continually engages in a comprehensive and iterative process of market analysis, stakeholder engagement and research and development, underpinned by a collaborative and data-driven approach. The stakeholders in the process are many, as they all have a distinct and valuable perspective: practitioners, patients and families, professional peak bodies and associations, educational institutions, non-governmental bodies and regulatory bodies. Through surveys, interviews, focus groups and advisory panels, industry gathers structured feedback for product development and remains grounded in real-world experience. Importantly, the product development process is held to rigorous ethical, clinical, regulatory and any other relevant compliance frameworks. These are non-negotiable, and transparency in the process and evidence gathering is foundational to the effective functioning of the ecosystem. 

Utilizing these principles and recognizing that no single product or tool is sufficient on its own, ZEISS developed the ZEISS Myopia Management Collective—a comprehensive ecosystem built around five core pillars, with each addressing a distinct but interconnected need.

Core Products for Myopia Management: At the core of the Collective are the products designed to slow myopia progression and to delay onset in pre-myopic eyes. ZEISS MyoCare spectacles are available globally across many countries, and ZEISS MyoEase are also available, in select countries. These are the current flagship spectacle lens solutions in the category. Following ZEISS’ acquisition of Brighten Optix in 2025, orthokeratology lenses are set to join the portfolio in the near future. Together, these options allow practitioners to tailor myopia management to the individual patient.

Diagnostic and Monitoring Tools: Complementing the core products are the diagnostic and monitoring tools to support evidence-based management. The ZEISS i.Profiler Plus enables precise measurement of refractive error, while the soon-to-be-available Myo200 biometer will enable practitioners to measure axial length. ZEISS MyoConsult, a myopia management and progression tracking software, closes the loop by enabling longitudinal monitoring of patient outcomes and turning data into actionable clinical steps. They work together to create a coherent patient journey from initial assessment and diagnosis through to selection of an appropriate strategy, to ongoing monitoring that allows practitioners to evaluate response and adjust treatment if needed. 

Education and Professional Development: The third pillar addresses education and professional development. The Myopia Insight Hub serves as a knowledge platform offering peer-contributed content, latest developments and free expert-designed education modules for practitioners at all levels of experience. In a field where evidence and guidelines are rapidly evolving, an accessible source of professional development is valuable especially for independent practitioners, and ZEISS is committed to raising the standard of myopia care across the profession – not simply among those already engaged in the issue.

The two remaining pillars include business assets and practice design and patient-centric workflows. These frameworks help practitioners set an effective practice pattern to communicate effectively with patients and their families and maintain engagement in what would be a typically multi-year journey. A child who has developed blurred vision due to myopia and appears in a practice needs the practitioner to advocate for their future eye health. In this regard, a practitioner who is equipped not only with the right tools and devices, but also with the right framework, will be able to support the child and their family on their journey. The patient-centric workflows within the Collective are designed to support this.

In summary, the effectiveness of any myopia management ecosystem rests on its ability to serve everyone within it. ZEISS is committed to providing the ecosystem to ensure that practitioners feel equipped, supported and confident to use them – for the benefit of every individual with myopia that walks through their door.